Online Purchasing Account You are logged on as Guest. LoginRegister a New AccountShopping cart (Empty)
United States 

Bombesin

 
BML-BP9115-0500 500 µg 51.00 USD
Do you need bulk/larger quantities?
 
Replaces Prod. #: ALX-152-018

Tetradecapeptide originally isolated from amphibian skin. Biologically active in the CNS and gastrointestinal tract of mammals. C-terminal -Leu-Met-NH2 containing peptide. Control peptide for Anti-Bombesin. Blocks immunoreactivity at 10 nmol/ml diluted antiserum.

Product Specification

Alternative Name:Blocking peptide for Bombesin pAb (Prod. No. BML-BA1115)
 
Sequence:pGln-Gln-Arg-Leu-Gly-Asn-Gln-Trp-Ala-Val-Gly-His-Leu-Met-NH2
 
Formula:C71H110N24O18S
 
MW:1619.9
 
Source:Synthetic.
 
CAS:31362-50-2
 
MI:14: 1329
 
Formulation:Lyophilized.
 
Purity:≥97% (HPLC)
 
Solubility:Soluble in water or aqueous buffers.
 
Shipping:Shipped on Blue Ice
 
Long Term Storage:-20°C
 
Use/Stability:Stable for at least 2 years after receipt when stored at -20°C.
 
Technical Info/Product Notes:Note: N-terminal glutamine cyclizes to form the pyroglutamyl peptide.
 

Product Literature References

Isolation and structure of bombesin and alytesin, 2 analogous active peptides from the skin of the European amphibians Bombina and Alytes: A. Anastasi, et al.; Experientia 27, 166 (1971), Abstract;

Related Products

Bombesin polyclonal antibody 

IHC | Print as PDF
 
BML-BA1115-0025 25 µl 100.00 USD
 
BML-BA1115-0100 100 µl 320.00 USD
Do you need bulk/larger quantities?
 

Product Toolbox

PRODUCT RESOURCES

Datasheet
MSDS
Certificate of Analysis

RELATED PRODUCTS

By target:
Bombesin receptor
By biological activity:
Bombesin receptor Ligand
By catalog section:

PRODUCT SUPPORT

FAQs
Technical Service
Customer Service

Related Literature

Brochures
Essential Research Tools for Neurodegeneration & Neural Signaling
Essential Research Tools for Neurodegeneration & Neural Signaling
Download as PDF

All new literature pieces

Recommend this page

 
For Research Use Only. Not for use in diagnostic procedures.
Keep in touch

©2017 Enzo Life Sciences, Inc.,